Advertisement

Topics

Novocure Announces Data Presentations at the American Association for Cancer Research Annual Meeting 2017

16:49 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Five-year survival analysis from the EF-14 phase 3 pivotal trial evaluating TTFields in combination with temozolomide for newly diagnosed glioblastoma to be shared in an oral presentation PANOVA clinical data to be pres...

Other Sources for this Article

Novocure
Media and Investor Contact:
Ashley Cordova, 212-767-7558
acordova@novocure.com

NEXT ARTICLE

More From BioPortfolio on "Novocure Announces Data Presentations at the American Association for Cancer Research Annual Meeting 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...